Arvee Laboratories (India) Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Arvee Laboratories (India) Ltd. generated cash of $36,635,380, which is more than the previous year. Cash used in financing activities reached the amount of -$1,876,530 last year. Net change in cash is therefore $13,126,010.
Cash Flow
| 2016 | 62.26M | -45.16M | -12.59M |
|---|---|---|---|
| 2018 | 60.16M | -12.31M | -37.82M |
| 2020 | 103.33M | -30.84M | -99.18M |
| 2021 | 17.10M | -6.04M | 45.20M |
| 2023 | 29.28M | -12.57M | -24.16M |
| 2024 | 36.63M | -21.63M | -1.87M |
ARVEE.NS Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 5.37M | 12.83M | 9.78M | 36.47M | 9.63M | 8.03M |
Operating activities | ||||||
Net income | 10.51M | 61.65M | 36.41M | 30.90M | 19.15M | 5.35M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 14.99M | 20.81M | 24.68M | 23.50M | 21.56M | 14.85M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 61.48M | -1.34M | -13.66M | 14.00M | -72.68M | -44.90M |
Inventories | -18.26M | 11.58M | -9.63M | -18.58M | -19.34M | -6.96M |
Accounts payable | -12.92M | -22.84M | -2.68M | 32.76M | 0 | 0 |
Cash generated by operating activities | 36.63M | 29.28M | 17.10M | 103.33M | 60.16M | 62.26M |
Investing activities | ||||||
Purchases Of Investments | 0 | -170K | -491K | -11.44M | 0 | 0 |
Investments In Property Plant And Equipment | -25.85M | -14.84M | -22.90M | -22.85M | -13.39M | -46.17M |
Acquisitions Net | 0 | 170K | 491K | 9.38M | 0 | 0 |
Cash generated by investing activities | -21.63M | -12.57M | -6.04M | -30.84M | -12.31M | -45.16M |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 14.6M | 10.5M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -21.31M | -50.12M | -90.06M | -91.19M | 7.63M |
Cash used in financing activities | -1.87M | -24.16M | 45.20M | -99.18M | -37.82M | -12.59M |
Net Change In Cash | 13.12M | -7.45M | 56.26M | -26.69M | 10.02M | 4.50M |
Cash at end of period | 18.50M | 5.37M | 66.05M | 9.78M | 19.65M | 12.54M |
| Data source | Data source | Data source | Data source | Data source | Data source |